Clene Inc. to Participate in Global Conference; CEO Available for Meetings
Clene Inc. announces participation in global conference with CEO available for meetings. Learn about CNM-Au8® and its potential impact on neurodegenerative diseases. Stay updated on Clene's innovative therapies.
This news matters as it highlights Clene's involvement in a major conference and the potential of its innovative therapy for neurodegenerative diseases. Investors and individuals interested in advancements in healthcare should take note of Clene's developments.